Selected research
Market Structure
Global Epilepsy Devices Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Epilepsy Devices market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Epilepsy Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Epilepsy Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Epilepsy Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Epilepsy Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Epilepsy Devices include Medtronic, Nihon Kohden Corporation, Neuropace, Natus Medical Incorporated, Medpage, MC10, Liva Nova, Koninklijke Philips and Jude Medical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Epilepsy Devices market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Epilepsy Devices and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Epilepsy Devices sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Epilepsy Devices market size, projected growth trends, production technologies, key applications, and end-use industries.
Epilepsy Devices Segment by Company
Medtronic
Nihon Kohden Corporation
Neuropace
Natus Medical Incorporated
Medpage
MC10
Liva Nova
Koninklijke Philips
Jude Medical
Empatica
Compumedics
Cerbomed
Boston Scientific Corporation
Epilepsy Devices Segment by Type
Conventional Devices
Wearable Devices
Implantable Devices
Epilepsy Devices Segment by Application
Hospitals
Neurology Centers
Others
Epilepsy Devices Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Epilepsy Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Epilepsy Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Epilepsy Devices.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Epilepsy Devices market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Epilepsy Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Epilepsy Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Epilepsy Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Conventional Devices
- Wearable Devices
- Implantable Devices
Applications
- Hospitals
- Neurology Centers
- Others
Companies covered
- Medtronic
- Nihon Kohden Corporation
- Neuropace
- Natus Medical Incorporated
- Medpage
- MC10
- Liva Nova
- Koninklijke Philips
- Jude Medical
- Empatica
- Compumedics
- Cerbomed
- Boston Scientific Corporation
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Epilepsy Devices Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Epilepsy Devices Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Epilepsy Devices Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Epilepsy Devices Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Epilepsy Devices Market Dynamics
- 2.1 Epilepsy Devices Industry Trends
- 2.2 Epilepsy Devices Industry Drivers
- 2.3 Epilepsy Devices Industry Opportunities and Challenges
- 2.4 Epilepsy Devices Industry Restraints
3 Epilepsy Devices Market by Manufacturers
- 3.1 Global Epilepsy Devices Revenue by Manufacturers (2021-2026)
- 3.2 Global Epilepsy Devices Sales by Manufacturers (2021-2026)
- 3.3 Global Epilepsy Devices Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Epilepsy Devices Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Epilepsy Devices Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Epilepsy Devices Manufacturers, Product Type & Application
- 3.7 Global Epilepsy Devices Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Epilepsy Devices Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Epilepsy Devices Players Market Share by Revenue in 2025
- 3.8.3 2025 Epilepsy Devices Tier 1, Tier 2, and Tier 3
4 Epilepsy Devices Market by Type
- 4.1 Epilepsy Devices Type Introduction
- 4.1.1 Conventional Devices
- 4.1.2 Wearable Devices
- 4.1.3 Implantable Devices
- 4.2 Global Epilepsy Devices Sales by Type
- 4.2.1 Global Epilepsy Devices Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Epilepsy Devices Sales by Type (2021-2032)
- 4.2.3 Global Epilepsy Devices Sales Market Share by Type (2021-2032)
- 4.3 Global Epilepsy Devices Revenue by Type
- 4.3.1 Global Epilepsy Devices Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Epilepsy Devices Revenue by Type (2021-2032)
- 4.3.3 Global Epilepsy Devices Revenue Market Share by Type (2021-2032)
5 Epilepsy Devices Market by Application
- 5.1 Epilepsy Devices Application Introduction
- 5.1.1 Hospitals
- 5.1.2 Neurology Centers
- 5.1.3 Others
- 5.2 Global Epilepsy Devices Sales by Application
- 5.2.1 Global Epilepsy Devices Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Epilepsy Devices Sales by Application (2021-2032)
- 5.2.3 Global Epilepsy Devices Sales Market Share by Application (2021-2032)
- 5.3 Global Epilepsy Devices Revenue by Application
- 5.3.1 Global Epilepsy Devices Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Epilepsy Devices Revenue by Application (2021-2032)
- 5.3.3 Global Epilepsy Devices Revenue Market Share by Application (2021-2032)
6 Global Epilepsy Devices Sales by Region
- 6.1 Global Epilepsy Devices Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Epilepsy Devices Sales by Region (2021-2032)
- 6.2.1 Global Epilepsy Devices Sales by Region (2021-2026)
- 6.2.2 Global Epilepsy Devices Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Epilepsy Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Epilepsy Devices Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Epilepsy Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Epilepsy Devices Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Epilepsy Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Epilepsy Devices Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Epilepsy Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Epilepsy Devices Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Epilepsy Devices Revenue by Region
- 7.1 Global Epilepsy Devices Revenue by Region
- 7.1.1 Global Epilepsy Devices Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Epilepsy Devices Revenue by Region (2021-2026)
- 7.1.3 Global Epilepsy Devices Revenue by Region (2027-2032)
- 7.1.4 Global Epilepsy Devices Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Epilepsy Devices Revenue (2021-2032)
- 7.2.2 North America Epilepsy Devices Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Epilepsy Devices Revenue (2021-2032)
- 7.3.2 Europe Epilepsy Devices Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Epilepsy Devices Revenue (2021-2032)
- 7.4.2 Asia-Pacific Epilepsy Devices Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Epilepsy Devices Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Epilepsy Devices Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Medtronic
- 8.1.1 Medtronic Company Information
- 8.1.2 Medtronic Business Overview
- 8.1.3 Medtronic Epilepsy Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Medtronic Epilepsy Devices Product Portfolio
- 8.1.5 Medtronic Recent Developments
- 8.2 Nihon Kohden Corporation
- 8.2.1 Nihon Kohden Corporation Company Information
- 8.2.2 Nihon Kohden Corporation Business Overview
- 8.2.3 Nihon Kohden Corporation Epilepsy Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Nihon Kohden Corporation Epilepsy Devices Product Portfolio
- 8.2.5 Nihon Kohden Corporation Recent Developments
- 8.3 Neuropace
- 8.3.1 Neuropace Company Information
- 8.3.2 Neuropace Business Overview
- 8.3.3 Neuropace Epilepsy Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Neuropace Epilepsy Devices Product Portfolio
- 8.3.5 Neuropace Recent Developments
- 8.4 Natus Medical Incorporated
- 8.4.1 Natus Medical Incorporated Company Information
- 8.4.2 Natus Medical Incorporated Business Overview
- 8.4.3 Natus Medical Incorporated Epilepsy Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Natus Medical Incorporated Epilepsy Devices Product Portfolio
- 8.4.5 Natus Medical Incorporated Recent Developments
- 8.5 Medpage
- 8.5.1 Medpage Company Information
- 8.5.2 Medpage Business Overview
- 8.5.3 Medpage Epilepsy Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Medpage Epilepsy Devices Product Portfolio
- 8.5.5 Medpage Recent Developments
- 8.6 MC10
- 8.6.1 MC10 Company Information
- 8.6.2 MC10 Business Overview
- 8.6.3 MC10 Epilepsy Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 MC10 Epilepsy Devices Product Portfolio
- 8.6.5 MC10 Recent Developments
- 8.7 Liva Nova
- 8.7.1 Liva Nova Company Information
- 8.7.2 Liva Nova Business Overview
- 8.7.3 Liva Nova Epilepsy Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Liva Nova Epilepsy Devices Product Portfolio
- 8.7.5 Liva Nova Recent Developments
- 8.8 Koninklijke Philips
- 8.8.1 Koninklijke Philips Company Information
- 8.8.2 Koninklijke Philips Business Overview
- 8.8.3 Koninklijke Philips Epilepsy Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Koninklijke Philips Epilepsy Devices Product Portfolio
- 8.8.5 Koninklijke Philips Recent Developments
- 8.9 Jude Medical
- 8.9.1 Jude Medical Company Information
- 8.9.2 Jude Medical Business Overview
- 8.9.3 Jude Medical Epilepsy Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Jude Medical Epilepsy Devices Product Portfolio
- 8.9.5 Jude Medical Recent Developments
- 8.10 Empatica
- 8.10.1 Empatica Company Information
- 8.10.2 Empatica Business Overview
- 8.10.3 Empatica Epilepsy Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Empatica Epilepsy Devices Product Portfolio
- 8.10.5 Empatica Recent Developments
- 8.11 Compumedics
- 8.11.1 Compumedics Company Information
- 8.11.2 Compumedics Business Overview
- 8.11.3 Compumedics Epilepsy Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Compumedics Epilepsy Devices Product Portfolio
- 8.11.5 Compumedics Recent Developments
- 8.12 Cerbomed
- 8.12.1 Cerbomed Company Information
- 8.12.2 Cerbomed Business Overview
- 8.12.3 Cerbomed Epilepsy Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Cerbomed Epilepsy Devices Product Portfolio
- 8.12.5 Cerbomed Recent Developments
- 8.13 Boston Scientific Corporation
- 8.13.1 Boston Scientific Corporation Company Information
- 8.13.2 Boston Scientific Corporation Business Overview
- 8.13.3 Boston Scientific Corporation Epilepsy Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 Boston Scientific Corporation Epilepsy Devices Product Portfolio
- 8.13.5 Boston Scientific Corporation Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Epilepsy Devices Value Chain Analysis
- 9.1.1 Epilepsy Devices Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Epilepsy Devices Production Mode & Process
- 9.2 Epilepsy Devices Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Epilepsy Devices Distributors
- 9.2.3 Epilepsy Devices Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst